{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:57:57Z","timestamp":1791475077100,"version":"4.3.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,13]],"date-time":"2021-11-13T00:00:00Z","timestamp":1636761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,11,13]],"date-time":"2021-11-13T00:00:00Z","timestamp":1636761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s12020-021-02927-3","type":"journal-article","created":{"date-parts":[[2021,11,13]],"date-time":"2021-11-13T11:02:37Z","timestamp":1636801357000},"page":"23-32","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["A contemporary clinical approach to genetic testing for heritable hyperparathyroidism syndromes"],"prefix":"10.1007","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0127-6482","authenticated-orcid":false,"given":"Sunita M. C.","family":"De Sousa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick J.","family":"Clifton-Bligh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,13]]},"reference":[{"issue":"4","key":"2927_CR1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/cen.14254","volume":"93","author":"S Mariathasan","year":"2020","unstructured":"S. Mariathasan, K.A. Andrews, E. Thompson, B.G. Challis, S. Wilcox, H. Pierce et al. Genetic testing for hereditary hyperparathyroidism and familial hypocalciuric hypercalcaemia in a large UK cohort. Clin. Endocrinol. (Oxf.) 93(4), 409\u201318 (2020)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"6","key":"2927_CR2","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/joim.12523","volume":"280","author":"RV Thakker","year":"2016","unstructured":"R.V. Thakker, Genetics of parathyroid tumours. J. Intern. Med. 280(6), 574\u201383 (2016)","journal-title":"J. Intern. Med."},{"issue":"10","key":"2927_CR3","doi-asserted-by":"publisher","first-page":"T195","DOI":"10.1530\/ERC-17-0243","volume":"24","author":"R Alrezk","year":"2017","unstructured":"R. Alrezk, F. Hannah-Shmouni, C.A. Stratakis, MEN4 and CDKN1B mutations: the latest of the MEN syndromes. Endocr. Relat. Cancer 24(10), T195\u2013T208 (2017)","journal-title":"Endocr. Relat. Cancer"},{"issue":"9","key":"2927_CR4","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1210\/jc.2019-00082","volume":"104","author":"A Frederiksen","year":"2019","unstructured":"A. Frederiksen, M. Rossing, P. Hermann, C. Ejersted, R.V. Thakker, M. Frost, Clinical Features of Multiple Endocrine Neoplasia Type 4: Novel Pathogenic Variant and Review of Published Cases. J. Clin. Endocrinol. Metab. 104(9), 3637\u201346 (2019)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"2927_CR5","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.ajhg.2016.08.018","volume":"99","author":"B Guan","year":"2016","unstructured":"B. Guan, J.M. Welch, J.C. Sapp, H. Ling, Y. Li, J.J. Johnston et al. GCM2-Activating Mutations in Familial Isolated Hyperparathyroidism. Am. J. Hum. Genet 99(5), 1034\u201344 (2016)","journal-title":"Am. J. Hum. Genet"},{"issue":"3","key":"2927_CR6","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/cen.14211","volume":"93","author":"C Mouly","year":"2020","unstructured":"C. Mouly, R. Vargas-Poussou, A. Lienhardt, C. Silve, M. Hureaux, C. Magdelaine et al. Clinical characteristics of familial hypocalciuric hypercalcaemia type 1: A multicentre study of 77 adult patients. Clin. Endocrinol. (Oxf.) 93(3), 248\u201360 (2020)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"5","key":"2927_CR7","first-page":"2042","volume":"85","author":"T Carling","year":"2000","unstructured":"T. Carling, E. Szabo, M. Bai, P. Ridefelt, G. Westin, P. Gustavsson et al. Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor. J. Clin. Endocrinol. Metab. 85(5), 2042\u20137 (2000)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"2927_CR8","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/s41588-019-0528-2","volume":"51","author":"AR Martin","year":"2019","unstructured":"A.R. Martin, E. Williams, R.E. Foulger, S. Leigh, L.C. Daugherty, O. Niblock et al. PanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels. Nat. Genet 51(11), 1560\u20135 (2019)","journal-title":"Nat. Genet"},{"issue":"10","key":"2927_CR9","doi-asserted-by":"publisher","first-page":"e0186485","DOI":"10.1371\/journal.pone.0186485","volume":"12","author":"E Pardi","year":"2017","unstructured":"E. Pardi, S. Borsari, F. Saponaro, F. Bogazzi, C. Urbani, S. Mariotti et al. Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features. PLoS ONE 12(10), e0186485 (2017)","journal-title":"PLoS ONE"},{"issue":"6","key":"2927_CR10","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.surg.2014.08.004","volume":"156","author":"A Mehta","year":"2014","unstructured":"A. Mehta, D. Patel, A. Rosenberg, M. Boufraqech, R.J. Ellis, N. Nilubol et al. Hyperparathyroidism-jaw tumor syndrome: Results of operative management. Surgery 156(6), 1315\u201324 (2014). discussion 24-5","journal-title":"Surgery"},{"issue":"9","key":"2927_CR11","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1210\/jc.2012-1230","volume":"97","author":"RV Thakker","year":"2012","unstructured":"R.V. Thakker, P.J. Newey, G.V. Walls, J. Bilezikian, H. Dralle, P.R. Ebeling et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J. Clin. Endocrinol. Metab. 97(9), 2990\u20133011 (2012)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"2927_CR12","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1210\/jc.2014-1414","volume":"99","author":"R Eastell","year":"2014","unstructured":"R. Eastell, M.L. Brandi, A.G. Costa, P. D'Amour, D.M. Shoback, R.V. Thakker, Diagnosis of asymptomatic primary. J. Clin. Endocrinol. Metab. 99(10), 3570\u20139 (2014). hyperparathyroidism: proceedings of the Fourth International Workshop","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2927_CR13","unstructured":"Guide for health professionals ordering genetic testing, V.1 2020 [https:\/\/www.eviq.org.au\/]"},{"key":"2927_CR14","unstructured":"MEN1 genetic testing, V.5 2019 [https:\/\/www.eviq.org.au\/]]"},{"key":"2927_CR15","unstructured":"CDC73 genetic testing, V.2 2019 [https:\/\/www.eviq.org.au\/]]"},{"key":"2927_CR16","unstructured":"RET (MEN2) genetic testing, V.4 2019 [https:\/\/www.eviq.org.au\/]"},{"issue":"1","key":"2927_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00198-016-3716-2","volume":"28","author":"AA Khan","year":"2017","unstructured":"A.A. Khan, D.A. Hanley, R. Rizzoli, J. Bollerslev, J.E.M. Young, L. Rejnmark et al. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos. Int 28(1), 1\u201319 (2017)","journal-title":"Osteoporos. Int"},{"issue":"8","key":"2927_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1530\/EC-17-0126","volume":"6","author":"E Mamedova","year":"2017","unstructured":"E. Mamedova, N. Mokrysheva, E. Vasilyev, V. Petrov, E. Pigarova, S. Kuznetsov et al. Primary hyperparathyroidism in young patients in Russia: high frequency of hyperparathyroidism-jaw tumor syndrome. Endocr. Connect. 6(8), 557\u201365 (2017)","journal-title":"Endocr. Connect."},{"issue":"10","key":"2927_CR19","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1210\/jc.2014-2000","volume":"99","author":"R Udelsman","year":"2014","unstructured":"R. Udelsman, G. \u00c5kerstr\u00f6m, C. Biagini, Q.Y. Duh, P. Miccoli, B. Niederle et al. The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J. Clin. Endocrinol. Metab. 99(10), 3595\u2013606 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"2927_CR20","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","volume":"151","author":"SM Wilhelm","year":"2016","unstructured":"S.M. Wilhelm, T.S. Wang, D.T. Ruan, J.A. Lee, S.L. Asa, Q.Y. Duh et al. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. JAMA Surg. 151(10), 959\u201368 (2016)","journal-title":"JAMA Surg."},{"issue":"8","key":"2927_CR21","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00423-015-1342-7","volume":"400","author":"M Iacobone","year":"2015","unstructured":"M. Iacobone, B. Carnaille, F.F. Palazzo, M. Vriens, Hereditary hyperparathyroidism\u2013a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbecks Arch. Surg. 400(8), 867\u201386 (2015)","journal-title":"Langenbecks Arch. Surg."},{"issue":"3","key":"2927_CR22","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s12020-017-1241-5","volume":"55","author":"A Szalat","year":"2017","unstructured":"A. Szalat, S. Shpitzen, A. Tsur, I. Zalmon Koren, S. Shilo, L. Tripto-Shkolnik et al. Stepwise CaSR, AP2S1, and GNA11 sequencing in patients with suspected familial hypocalciuric hypercalcemia. Endocrine 55(3), 741\u20137 (2017)","journal-title":"Endocrine"},{"issue":"1-2","key":"2927_CR23","first-page":"44","volume":"3","author":"LF Starker","year":"2012","unstructured":"L.F. Starker, T. Akerstr\u00f6m, W.D. Long, A. Delgado-Verdugo, P. Donovan, R. Udelsman et al. Frequent germ-line mutations of the MEN1, CASR, and HRPT2\/CDC73 genes in young patients with clinically non-familial primary hyperparathyroidism. Horm. Cancer 3(1-2), 44\u201351 (2012)","journal-title":"Cancer"},{"issue":"6","key":"2927_CR24","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.surg.2008.07.030","volume":"144","author":"L Yip","year":"2008","unstructured":"L. Yip, J.B. Ogilvie, S.M. Challinor, R.A. Salata, D.L. Thull, J.H. Yim et al. Identification of multiple endocrine neoplasia type 1 in patients with apparent sporadic primary hyperparathyroidism. Surgery 144(6), 1002\u20136 (2008). discussion 6-7","journal-title":"Surgery"},{"issue":"18","key":"2927_CR25","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1056\/NEJMoa031237","volume":"349","author":"TM Shattuck","year":"2003","unstructured":"T.M. Shattuck, S. V\u00e4lim\u00e4ki, T. Obara, R.D. Gaz, O.H. Clark, D. Shoback et al. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N. Engl. J. Med. 349(18), 1722\u20139 (2003)","journal-title":"N. Engl. J. Med"},{"issue":"5","key":"2927_CR26","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jamcollsurg.2018.01.007","volume":"226","author":"M El Lakis","year":"2018","unstructured":"M. El Lakis, P. Nockel, A. Gaitanidis, B. Guan, S. Agarwal, J. Welch et al. Probability of Positive Genetic Testing Results in Patients with Family History of Primary Hyperparathyroidism. J. Am. Coll. Surg. 226(5), 933\u20138 (2018)","journal-title":"J. Am. Coll. Surg."},{"issue":"5","key":"2927_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"S. Richards, N. Aziz, S. Bale, D. Bick, S. Das, J. Gastier-Foster et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17(5), 405\u201324 (2015)","journal-title":"Genet. Med."},{"issue":"1","key":"2927_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/PAS.0000000000001017","volume":"43","author":"AJ Gill","year":"2019","unstructured":"A.J. Gill, G. Lim, V.K.Y. Cheung, J. Andrici, J.L. Perry-Keene, J. Paik et al. Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features. Am. J. Surg. Pathol. 43(1), 35\u201346 (2019)","journal-title":"Am. J. Surg. Pathol."},{"issue":"12","key":"2927_CR29","doi-asserted-by":"publisher","first-page":"bvaa071","DOI":"10.1210\/jendso\/bvaa071","volume":"4","author":"SMC De Sousa","year":"2020","unstructured":"S.M.C. De Sousa, J. Toubia, T.S.E. Hardy, J. Feng, P. Wang, A.W. Schreiber et al. Aberrant Splicing of SDHC in Families With Unexplained Succinate Dehydrogenase-Deficient Paragangliomas. J. Endocr. Soc. 4(12), bvaa071\u2013bvaa (2020)","journal-title":"J. Endocr. Soc."},{"issue":"9","key":"2927_CR30","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1158\/1055-9965.EPI-05-0706","volume":"15","author":"T Rylander-Rudqvist","year":"2006","unstructured":"T. Rylander-Rudqvist, N. H\u00e5kansson, G. Tybring, A. Wolk, Quality and quantity of saliva DNA obtained from the self-administrated oragene method\u2013a pilot study on the cohort of Swedish men. Cancer Epidemiol. Biomark. Prev. 15(9), 1742\u20135 (2006)","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"9","key":"2927_CR31","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1210\/jc.2007-0476","volume":"92","author":"E Tham","year":"2007","unstructured":"E. Tham, U. Grandell, E. Lindgren, G. Toss, B. Skogseid, M. Nordenskj\u00f6ld, Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases. J. Clin. Endocrinol. Metab. 92(9), 3389\u201395 (2007)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"2927_CR32","doi-asserted-by":"publisher","first-page":"E403","DOI":"10.1210\/jc.2012-2789","volume":"98","author":"L Bricaire","year":"2013","unstructured":"L. Bricaire, M.F. Odou, C. Cardot-Bauters, B. Delemer, M.O. North, S. Salenave et al. Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 98(2), E403\u20138 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"2927_CR33","first-page":"e10362","volume":"4","author":"AR Jones","year":"2020","unstructured":"A.R. Jones, M.J. Hare, J. Brown, J. Yang, C. Meyer, F. Milat et al. Familial Hypocalciuric Hypercalcemia in Pregnancy: Diagnostic Pitfalls. JBMR 4(6), e10362 (2020)","journal-title":"JBMR"},{"issue":"4","key":"2927_CR34","first-page":"880","volume":"56","author":"N Janicic","year":"1995","unstructured":"N. Janicic, Z. Pausova, D.E. Cole, G.N. Hendy, Insertion of an Alu sequence in the Ca(2+)-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Am. J. Hum. Genet. 56(4), 880\u20136 (1995)","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"2927_CR35","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1172\/JCI117062","volume":"93","author":"MR Pollak","year":"1994","unstructured":"M.R. Pollak, Y.H. Chou, S.J. Marx, B. Steinmann, D.E. Cole, M.L. Brandi et al. Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype. J. Clin. Investig. 93(3), 1108\u201312 (1994)","journal-title":"J. Clin. Investig."},{"issue":"6","key":"2927_CR36","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.ajhg.2020.04.006","volume":"106","author":"R Dershem","year":"2020","unstructured":"R. Dershem, C.M. Gorvin, R.P.R. Metpally, S. Krishnamurthy, D.T. Smelser, F.M. Hannan et al. Familial Hypocalciuric Hypercalcemia Type 1 and Autosomal-Dominant Hypocalcemia Type 1: Prevalence in a Large Healthcare Population. Am. J. Hum. Genet 106(6), 734\u201347 (2020)","journal-title":"Am. J. Hum. Genet"},{"issue":"1","key":"2927_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005792-200201000-00001","volume":"81","author":"WF Simonds","year":"2002","unstructured":"W.F. Simonds, L.A. James-Newton, S.K. Agarwal, B. Yang, M.C. Skarulis, G.N. Hendy et al. Familial isolated hyperparathyroidism: clinical and genetic characteristics of 36 kindreds. Medicine 81(1), 1\u201326 (2002)","journal-title":"Medicine"},{"issue":"1","key":"2927_CR38","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1210\/jc.2003-030675","volume":"89","author":"WF Simonds","year":"2004","unstructured":"W.F. Simonds, C.M. Robbins, S.K. Agarwal, G.N. Hendy, J.D. Carpten, S.J. Marx, Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome. J. Clin. Endocrinol. Metab. 89(1), 96\u2013102 (2004)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"2927_CR39","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1136\/jmg.2003.016725","volume":"41","author":"J Warner","year":"2004","unstructured":"J. Warner, M. Epstein, A. Sweet, D. Singh, J. Burgess, S. Stranks et al. Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications. J. Med. Genet. 41(3), 155\u201360 (2004)","journal-title":"J. Med. Genet."},{"issue":"2","key":"2927_CR40","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1365-2265.2006.02438.x","volume":"64","author":"F Cetani","year":"2006","unstructured":"F. Cetani, E. Pardi, E. Ambrogini, M. Lemmi, S. Borsari, L. Cianferotti et al. Genetic analyses in familial isolated hyperparathyroidism: implication for clinical assessment and surgical management. Clin. Endocrinol. 64(2), 146\u201352 (2006)","journal-title":"Clin. Endocrinol."},{"issue":"6","key":"2927_CR41","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1007\/s00268-009-0388-5","volume":"34","author":"A Skandarajah","year":"2010","unstructured":"A. Skandarajah, A. Barlier, N. Morlet-Barlat, F. Sebag, A. Enjalbert, B. Conte-Devolx et al. Should routine analysis of the MEN1 gene be performed in all patients with primary hyperparathyroidism under 40 years of age? World J. Surg. 34(6), 1294\u20138 (2010)","journal-title":"World J. Surg."},{"issue":"1-2","key":"2927_CR42","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s12672-011-0100-8","volume":"3","author":"LF Starker","year":"2012","unstructured":"L.F. Starker, T. \u00c5kerstr\u00f6m, W.D. Long, A. Delgado-Verdugo, P. Donovan, R. Udelsman et al. Frequent germ-line mutations of the MEN1, CASR, and HRPT2\/CDC73 genes in young patients with clinically non-familial primary hyperparathyroidism. Hormones Cancer 3(1-2), 44\u201351 (2012)","journal-title":"Hormones Cancer"},{"issue":"5","key":"2927_CR43","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jamcollsurg.2018.01.007","volume":"226","author":"M El Lakis","year":"2018","unstructured":"M. El Lakis, P. Nockel, A. Gaitanidis, B. Guan, S. Agarwal, J. Welch et al. Probability of positive genetic testing results in patients with family history of primary hyperparathyroidism. J. Am. Coll. Surg. 226(5), 933\u20138 (2018)","journal-title":"J. Am. Coll. Surg."},{"issue":"1","key":"2927_CR44","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1530\/EJE-18-0129","volume":"180","author":"A Garc\u00eda-Casta\u00f1o","year":"2019","unstructured":"A. Garc\u00eda-Casta\u00f1o, L. Madariaga, G.P. de Nanclares, G. Ariceta, S. Gaztambide, L. Casta\u00f1o, Novel mutations associated with inherited human calcium-sensing receptor disorders: A clinical genetic study. Eur. J. Endocrinol. 180(1), 59\u201370 (2019)","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"2927_CR45","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1530\/EJE-19-0641","volume":"182","author":"L Coppin","year":"2020","unstructured":"L. Coppin, M. Dufosse, P. Romanet, S. Giraud, M -O. North, C. Cardot-bauters, et al. Should the GCM2 gene be tested when screening for familial primary hyperparathyroidism? Eur. J. Endocrinol 182(1), 57\u201365 (2020)","journal-title":"Eur. J. Endocrinol"},{"issue":"2","key":"2927_CR46","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1530\/EJE-20-1119","volume":"184","author":"Y El Allali","year":"2021","unstructured":"Y. El Allali, C. Hermetet, J. Bacchetta, C. Amouroux, A. Rothenbuhler, V. Porquet-Bordes et al. Presenting features and molecular genetics of primary hyperparathyroidism in the paediatric population. Eur. J. Endocrinol. 184(2), 347\u201355 (2021)","journal-title":"Eur. J. Endocrinol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02927-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-021-02927-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02927-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T06:54:12Z","timestamp":1675925652000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-021-02927-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,13]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["2927"],"URL":"https:\/\/doi.org\/10.1007\/s12020-021-02927-3","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,13]]},"assertion":[{"value":"14 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Publication approval was obtained from the Human Research Ethics Committees of the Central Adelaide Local Health Network and Northern Sydney Local Health District. Patient consent and ethical and governance approval were waived by both Committees in view of the retrospective nature of the audit and only summary data being published. Audit approval was sought and approved from the Wellington Regional Hospital audit committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}